Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D V Gold

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Molecular Immunology|June 1, 1992
Microheterogeneity of a purified IgG1 due to asymmetric Fab glycosylationR C Grebenau, D M Goldenberg, C H Chang, et al.
Cancer Research|February 1, 1990
Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigensR M Sharkey, D V Gold, R Aninipot, et al.
Cancer Research|December 1, 1995
Initial tumor targeting, biodistribution, and pharmacokinetic evaluation of the monoclonal antibody PAM4 in patients with pancreatic cancerG Mariani, N Molea, D Bacciardi, et al.
Cancer Research|April 15, 1996
Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumorsT M Behr, R M Sharkey, M I Juweid, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Molecular Immunology|June 1, 1992
Microheterogeneity of a purified IgG1 due to asymmetric Fab glycosylationR C Grebenau, D M Goldenberg, C H Chang, et al.
Cancer Research|February 1, 1990
Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigensR M Sharkey, D V Gold, R Aninipot, et al.
Cancer Research|December 1, 1995
Initial tumor targeting, biodistribution, and pharmacokinetic evaluation of the monoclonal antibody PAM4 in patients with pancreatic cancerG Mariani, N Molea, D Bacciardi, et al.
Cancer Research|April 15, 1996
Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumorsT M Behr, R M Sharkey, M I Juweid, et al.
Pageof 4